001     130910
005     20240228145558.0
024 7 _ |a 10.1002/pbc.26670
|2 doi
024 7 _ |a pmid:28598542
|2 pmid
024 7 _ |a 0098-1532
|2 ISSN
024 7 _ |a 1096-911X
|2 ISSN
024 7 _ |a 1545-5009
|2 ISSN
024 7 _ |a 1545-5017
|2 ISSN
024 7 _ |a altmetric:20929840
|2 altmetric
037 _ _ |a DKFZ-2017-05986
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Senfter, Daniel
|b 0
245 _ _ |a Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications.
260 _ _ |a New York, NY
|c 2017
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1525777704_9525
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Overexpression of minichromosome maintenance (MCM) proteins 2, 3, and 7 is associated with migration and invasion in medulloblastoma (MB). However, expression profiling of all prereplication complex (pre-RC) has not been addressed in MBs.We performed mRNA expression profiling of a large set of pre-RC elements in cell lines and tumor tissues of MB. RNAi technology was employed for functional studies in MB cell lines.Our data showed that most of the pre-RC components are significantly overexpressed in MB. Among all pre-RC mRNAs, MCM10 showed the highest level of expression (∼500- to 1,000-fold) in MB cell lines and tissues compared to the levels detected in cerebellum. In addition, RNAi silencing of MCM10 caused reduced cell proliferation and cell viability in MB cells.Taken together, our study reveals that the pre-RC is dysregulated in MB. In addition, MCM10, a member of this complex, is significantly overexpressed in MB and is required for tumor cell proliferation.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a MCM10 protein, human
|2 NLM Chemicals
650 _ 7 |a Minichromosome Maintenance Proteins
|0 EC 3.6.4.12
|2 NLM Chemicals
700 1 _ |a Erkan, Erdogan Pekcan
|b 1
700 1 _ |a Özer, Erdener
|b 2
700 1 _ |a Jungwirth, Gerhard
|b 3
700 1 _ |a Madlener, Sibylle
|b 4
700 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 5
|u dkfz
700 1 _ |a Ströbel, Thomas
|b 6
700 1 _ |a Saydam, Nurten
|0 0000-0002-0511-7721
|b 7
700 1 _ |a Saydam, Okay
|b 8
773 _ _ |a 10.1002/pbc.26670
|g Vol. 64, no. 12, p. e26670 -
|0 PERI:(DE-600)2130978-4
|n 12
|p e26670 -
|t Pediatric blood & cancer
|v 64
|y 2017
|x 1545-5009
909 C O |o oai:inrepo02.dkfz.de:130910
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PEDIATR BLOOD CANCER : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21